Ti-Dong Shan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ti-Dong Shan has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Yue Han
Department of Gastroenterology The Affiliated Hospital of Qingdao University Qingdao Shandong P. R. China
9 shared publicationsLi Chen
Qingdao University Department of Gastroenterology, The Affiliated Hospital of Qingdao University Qingdao, Shandong, 262000, P.R.
7 shared publicationsXue-Guo Sun
The Affiliated Hospital of Qingdao University, Shandong, China
6 shared publicationsFu-Guo Liu
The Affiliated Hospital of Qingdao University, Shandong, China
3 shared publicationsFu‐Guo Liu
Department of Gastroenterology, The Affiliated Hospital of Qingdao University Qingdao University Qingdao China
2 shared publications- Hui-Zi Liu
Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14
Recognizing Gastric Oxyntic Gland Neoplasms: Characteristic Endoscopic Appearance for Improved Detection
Background: Gastric oxyntic gland neoplasms (GOGNs)—including oxyntic gland adenoma (OGA), gastric adenocarcinoma of fundic gland type (GA-FG), and gastric adenocarcinoma of fundic gland mucosa type (GA-FGM)—are rare epithelial neoplasms that often lack overt malignant appearance on endoscopy. This study aimed to characterize the endoscopic features of GOGNs that may facilitate their recognition. Methods: We retrospectively analyzed consecutive, histologically confirmed GOGNs diagnosed at a tertiary center between January 2019 and July 2025. Endoscopic features on white-light endoscopy (WLE), magnifying narrow-band imaging (NBI), and endoscopic ultrasonography (EUS) were evaluated. Results: Among 156,240 upper endoscopic examinations, 35 patients were diagnosed with GOGNs (0.028%). Lesions were mostly small (median 6 mm) and located in the fundus/upper body (52%), predominantly Paris type 0-Ⅱa (57%) or subepithelial-like elevations (60%). Color was similar to the surrounding mucosa (49%) or mildly reddish (37%), occasionally showing branching vessels (31%) or focal pigmentation (14%). On NBI, OGA and GA-FG lesions (n = 12) frequently showed regularly enlarged crypt openings (92%) and branching vessels (83%) with ill-defined margins (75%), whereas GA-FGM (n = 4) more often showed a distinct demarcation line (75%) with irregular microvascular/microsurface patterns (50%). EUS demonstrated localization mainly within the middle-to-deep mucosal layer and occasional submucosal extension, with intact muscularis propria. Conclusions: GOGNs typically present as small, inconspicuous elevated lesions in the fundus or upper stomach, often with near-normal or slightly reddish mucosal color and characteristic surface vascular and magnifying features. Awareness of these endoscopic patterns may improve recognition of GOGNs during routine endoscopy. Larger studies are needed to validate these findings.
- 8 June 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14
Open AccessRecognizing Gastric Oxyntic Gland Neoplasms: Characteristic Endoscopic Appearance for Improved Detection
Background: Gastric oxyntic gland neoplasms (GOGNs)—including oxyntic gland adenoma (OGA), gastric adenocarcinoma of fundic gland type (GA-FG), and gastric adenocarcinoma of fundic gland mucosa type (GA-FGM)—are rare epithelial neoplasms that often lack overt malignant appearance on endoscopy. This study aimed to characterize the endoscopic features of GOGNs that may facilitate their recognition. Methods: We retrospectively analyzed consecutive, histologically confirmed GOGNs diagnosed at a tertiary center between January 2019 and July 2025. Endoscopic features on white-light endoscopy (WLE), magnifying narrow-band imaging (NBI), and endoscopic ultrasonography (EUS) were evaluated. Results: Among 156,240 upper endoscopic examinations, 35 patients were diagnosed with GOGNs (0.028%). Lesions were mostly small (median 6 mm) and located in the fundus/upper body (52%), predominantly Paris type 0-Ⅱa (57%) or subepithelial-like elevations (60%). Color was similar to the surrounding mucosa (49%) or mildly reddish (37%), occasionally showing branching vessels (31%) or focal pigmentation (14%). On NBI, OGA and GA-FG lesions (n = 12) frequently showed regularly enlarged crypt openings (92%) and branching vessels (83%) with ill-defined margins (75%), whereas GA-FGM (n = 4) more often showed a distinct demarcation line (75%) with irregular microvascular/microsurface patterns (50%). EUS demonstrated localization mainly within the middle-to-deep mucosal layer and occasional submucosal extension, with intact muscularis propria. Conclusions: GOGNs typically present as small, inconspicuous elevated lesions in the fundus or upper stomach, often with near-normal or slightly reddish mucosal color and characteristic surface vascular and magnifying features. Awareness of these endoscopic patterns may improve recognition of GOGNs during routine endoscopy. Larger studies are needed to validate these findings.
- 1 June 2026
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 44 (8)
CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state
Diabetic enteropathy (DE) is a common complication of diabetes mellitus (DM), yet its underlying molecular mechanisms remain poorly understood. Emerging evidence suggests that abnormal differentiation of intestinal epithelial stem cells (IESCs) contributes to early intestinal dysfunction in DM. In this study, we aimed to investigate the role of CircVapa in regulating IESC differentiation and to elucidate the underlying molecular mechanism involving the miR-212-3p/Smoc2 axis. In this study, IESCs were extracted from BKS.CgDock7m+/+Lepr db/JNju (DM) mice models. A circular RNA molecule, CircVapa, was identified as being markedly enriched in IESCs. Experimental suppression of CircVapa in diabetic mice attenuated abnormal differentiation of intestinal epithelial cells (IECs). Notably, CircVapa was identified as a critical mediator of Lgr5+ stem cell functionality in hyperglycemic conditions. Mechanistically, microarray analysis, bioinformatics analysis, and luciferase reporter assays demonstrated that CircVapa serves as a competitive endogenous RNA (ceRNA) by directly binding miR-212-3p, thereby regulating Smoc2 expression. Furthermore, CircVapa regulated abnormal IESC differentiation via the miR-212-3p/Smoc2 regulatory network in diabetic mice. Collectively, this study demonstrates an important role of CircVapa in regulating IEC differentiation during DM progression.
- 1 June 2026
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 44 (8)
CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state
Diabetic enteropathy (DE) is a common complication of diabetes mellitus (DM), yet its underlying molecular mechanisms remain poorly understood. Emerging evidence suggests that abnormal differentiation of intestinal epithelial stem cells (IESCs) contributes to early intestinal dysfunction in DM. In this study, we aimed to investigate the role of CircVapa in regulating IESC differentiation and to elucidate the underlying molecular mechanism involving the miR-212-3p/Smoc2 axis. In this study, IESCs were extracted from BKS.CgDock7m+/+Lepr db/JNju (DM) mice models. A circular RNA molecule, CircVapa, was identified as being markedly enriched in IESCs. Experimental suppression of CircVapa in diabetic mice attenuated abnormal differentiation of intestinal epithelial cells (IECs). Notably, CircVapa was identified as a critical mediator of Lgr5+ stem cell functionality in hyperglycemic conditions. Mechanistically, microarray analysis, bioinformatics analysis, and luciferase reporter assays demonstrated that CircVapa serves as a competitive endogenous RNA (ceRNA) by directly binding miR-212-3p, thereby regulating Smoc2 expression. Furthermore, CircVapa regulated abnormal IESC differentiation via the miR-212-3p/Smoc2 regulatory network in diabetic mice. Collectively, this study demonstrates an important role of CircVapa in regulating IEC differentiation during DM progression.
- Open Access
- 12 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Prebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites
The study investigated the dose-dependent protective effects of xylooligosaccharides (XOS) against metabolic dysfunction-associated steatotic liver disease (MASLD) in mice, focusing on gut microbiota and microbial metabolites. Male C57BL/6 mice were fed either a low-fat diet(LFD), a high-fat diet (HFD), HFD supplemented with low-dose XOS (0.38 g/kg), or HFD supplemented with high-dose XOS (1.0 g/kg) for 16 weeks. Hepatic histology, serum biochemistry, ileal morphology, gut microbiota composition (16 S rRNA gene sequencing), and fecal metabolites profiles were analyzed. High-dose XOS, but not low-dose, significantly reduced serum Alanine aminotransferase (ALT) and Triglycerides (TG) levels, alleviated hepatic steatosis, and improved the villus height–to–crypt depth ratio. It attenuated HFD-induced enrichment of Ruminococcaceae and Lachnospiraceae, while restoring the abundance of Bacteroidaceae, Bifidobacteriaceae and Bacillaceae. Metabolomic analysis revealed rebalancing of the tryptophan–indole and arachidonic-acid pathways, with reduced pro-inflammatory eicosanoids and kynurenine derivatives, and increased hepatoprotective indole derivatives and omega-3 polyunsaturated fatty acids. High-dose XOS reconstructs the gut microbiota-metabolite network toward an anti-inflammatory, hepatoprotective state in HFD-fed mice, underscoring the importance of dose optimization in XOS-based interventions for MASLD.
- 12 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPrebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites
The study investigated the dose-dependent protective effects of xylooligosaccharides (XOS) against metabolic dysfunction-associated steatotic liver disease (MASLD) in mice, focusing on gut microbiota and microbial metabolites. Male C57BL/6 mice were fed either a low-fat diet(LFD), a high-fat diet (HFD), HFD supplemented with low-dose XOS (0.38 g/kg), or HFD supplemented with high-dose XOS (1.0 g/kg) for 16 weeks. Hepatic histology, serum biochemistry, ileal morphology, gut microbiota composition (16 S rRNA gene sequencing), and fecal metabolites profiles were analyzed. High-dose XOS, but not low-dose, significantly reduced serum Alanine aminotransferase (ALT) and Triglycerides (TG) levels, alleviated hepatic steatosis, and improved the villus height–to–crypt depth ratio. It attenuated HFD-induced enrichment of Ruminococcaceae and Lachnospiraceae, while restoring the abundance of Bacteroidaceae, Bifidobacteriaceae and Bacillaceae. Metabolomic analysis revealed rebalancing of the tryptophan–indole and arachidonic-acid pathways, with reduced pro-inflammatory eicosanoids and kynurenine derivatives, and increased hepatoprotective indole derivatives and omega-3 polyunsaturated fatty acids. High-dose XOS reconstructs the gut microbiota-metabolite network toward an anti-inflammatory, hepatoprotective state in HFD-fed mice, underscoring the importance of dose optimization in XOS-based interventions for MASLD.
- Open Access
- 6 October 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-8
Endoscopic submucosal dissection in Helicobacter pylori-negative early gastric adenocarcinoma with diffuse large B-cell lymphoma: a two-case report and literature review
We describe two rare cases of synchronous early gastric adenocarcinoma (EGA) and diffuse large B-cell lymphoma (DLBCL) involving the stomach and colon in Helicobacter pylori-negative patients. Case 1: A 61-year-old male presenting with abdominal pain was diagnosed with synchronous EGA and colonic DLBCL via endoscopy. Following 8 cycles of R-CDOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). The patient subsequently underwent endoscopic submucosal dissection (ESD) for EGA without gastrectomy. Case 2: A 67-year-old male with a history of gastric DLBCL (treated with 9 cycles of R-CDOP within 6 months) was diagnosed with EGA on surveillance gastroscopy and managed with ESD. Both patients achieved complete resection and remained disease-free at 16-month follow-up. These cases highlight the feasibility of ESD as a curative option for Helicobacter pylori-negative EGA coexisting with DLBCL.
- 6 October 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-8
Open AccessEndoscopic submucosal dissection in Helicobacter pylori-negative early gastric adenocarcinoma with diffuse large B-cell lymphoma: a two-case report and literature review
We describe two rare cases of synchronous early gastric adenocarcinoma (EGA) and diffuse large B-cell lymphoma (DLBCL) involving the stomach and colon in Helicobacter pylori-negative patients. Case 1: A 61-year-old male presenting with abdominal pain was diagnosed with synchronous EGA and colonic DLBCL via endoscopy. Following 8 cycles of R-CDOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). The patient subsequently underwent endoscopic submucosal dissection (ESD) for EGA without gastrectomy. Case 2: A 67-year-old male with a history of gastric DLBCL (treated with 9 cycles of R-CDOP within 6 months) was diagnosed with EGA on surveillance gastroscopy and managed with ESD. Both patients achieved complete resection and remained disease-free at 16-month follow-up. These cases highlight the feasibility of ESD as a curative option for Helicobacter pylori-negative EGA coexisting with DLBCL.
- 9 January 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 266, 155819
Gastric duplication cysts with mixed hemangioma treated by endoscopic submucosal dissection: A case report and literature review
- 9 January 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 266, 155819
Gastric duplication cysts with mixed hemangioma treated by endoscopic submucosal dissection: A case report and literature review
- Open Access
- 28 June 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-11
Activation of lncRNA DANCR by H3K27 acetylation regulates proliferation of colorectal cancer cells
The long noncoding DANCR functions as a tumor oncogene in many cancers, including colorectal cancer (CRC). However, the molecular mechanism of DANCR in CRC has not been explored. This study probed the function and potential mechanism by which DANCR contributes to the progression of CRC. The obtained data indicated that DANCR is overexpressed in CRC tissues and cell lines. Knockdown of DANCR hindered CRC cell proliferation, which was mediated by cyclin D1 and CDK4. Bioinformatic analysis, luciferase reporter assays and subcellular fractionation verified that DANCR directly binds to miR-508-5p. Moreover, DANCR acts as a miR-508-5p ceRNA to regulate expression of ATF1. In addition, upregulation of DANCR is attributed to H3K27 acetylation at the promoter region. In conclusion, our study confirmed that activation of lncRNA DANCR by H3K27 acetylation has an oncogenic role in CRC progression and provides a potential therapeutic target for CRC.
- 28 June 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-11
Open AccessActivation of lncRNA DANCR by H3K27 acetylation regulates proliferation of colorectal cancer cells
The long noncoding DANCR functions as a tumor oncogene in many cancers, including colorectal cancer (CRC). However, the molecular mechanism of DANCR in CRC has not been explored. This study probed the function and potential mechanism by which DANCR contributes to the progression of CRC. The obtained data indicated that DANCR is overexpressed in CRC tissues and cell lines. Knockdown of DANCR hindered CRC cell proliferation, which was mediated by cyclin D1 and CDK4. Bioinformatic analysis, luciferase reporter assays and subcellular fractionation verified that DANCR directly binds to miR-508-5p. Moreover, DANCR acts as a miR-508-5p ceRNA to regulate expression of ATF1. In addition, upregulation of DANCR is attributed to H3K27 acetylation at the promoter region. In conclusion, our study confirmed that activation of lncRNA DANCR by H3K27 acetylation has an oncogenic role in CRC progression and provides a potential therapeutic target for CRC.
- 10 August 2023
- Published by Wiley in Journal of Cellular Physiology
- Vol. 238 (10) , 2361-2372
Mettl14‐mediated m6A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state
Diabetes mellitus (DM) and its related complications are a global epidemic characterized by high morbidity and mortality. However, little is known about diabetic enteropathy (DE) and its the potential underlying mechanism. Intestinal epithelial stem cells (IESCs) were harvested from experimental mice, and the levels of dominant N6‐methyladenosine (m6A)‐related enzyme were detected by RT‐PCR, Western blotting, immunohistochemistry. The role of Mettl14 in the abnormal differentiation of intestinal epithelial cells (IECs) during DM was confirmed by knockdown experiments. RT‐PCR, MeRIP, and bioinformatics analysis were carried out to confirm the downstream target of Mettl14. Through bioinformatics analysis, RT‐PCR, and Western blotting, we further analyzed the differentiation‐related gene in the IECs from mice with DM. In this study, the levels of Mettl14 and m6A were higher in db/db mice than that in control mice. And abnormal differentiation of IECs in DM was associated with Mettl14 overexpression. Additionally, Mettl14 is a major determinant of IESCs identity and organoid‐forming upon DM state. Mechanistically, we revealed that the candidate binding target of Mettl14 was Fzd2 mRNA and affected Fzd2 stability. Moreover, Mettl14 downregulation was observed to attenuate the abnormal differentiation of IECs through modulating Fzd2 m6A modification in DM state. Together, our results provide definitive evidence for the essential role of Mettl14 in differentiation of IESCs in DM state.
- 10 August 2023
- Published by Wiley in Journal of Cellular Physiology
- Vol. 238 (10) , 2361-2372
Mettl14‐mediated m6A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state
Diabetes mellitus (DM) and its related complications are a global epidemic characterized by high morbidity and mortality. However, little is known about diabetic enteropathy (DE) and its the potential underlying mechanism. Intestinal epithelial stem cells (IESCs) were harvested from experimental mice, and the levels of dominant N6‐methyladenosine (m6A)‐related enzyme were detected by RT‐PCR, Western blotting, immunohistochemistry. The role of Mettl14 in the abnormal differentiation of intestinal epithelial cells (IECs) during DM was confirmed by knockdown experiments. RT‐PCR, MeRIP, and bioinformatics analysis were carried out to confirm the downstream target of Mettl14. Through bioinformatics analysis, RT‐PCR, and Western blotting, we further analyzed the differentiation‐related gene in the IECs from mice with DM. In this study, the levels of Mettl14 and m6A were higher in db/db mice than that in control mice. And abnormal differentiation of IECs in DM was associated with Mettl14 overexpression. Additionally, Mettl14 is a major determinant of IESCs identity and organoid‐forming upon DM state. Mechanistically, we revealed that the candidate binding target of Mettl14 was Fzd2 mRNA and affected Fzd2 stability. Moreover, Mettl14 downregulation was observed to attenuate the abnormal differentiation of IECs through modulating Fzd2 m6A modification in DM state. Together, our results provide definitive evidence for the essential role of Mettl14 in differentiation of IESCs in DM state.
- RetractionOpen Access
- 20 March 2023
- Published by Spandidos Publications in Oncology Reports
- Vol. 49 (5) , 1
[Retracted] Long noncoding RNA UCID sponges miR‑152‑3p to promote colorectal cancer cell migration and invasion via the Wnt/β‑catenin signaling pathway
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that there appeared to be matching data panels comparing between the Transwell invasion and migration assays shown in Figs. 2C and 5C; moreover, one of the data panels shown in Fig. 2D had previously appeared in a paper written largely by different authors (the author ‘T‑D Shan’ was held in common) at different research institutes in the journal Oncotarget in 2016 [Shan T‑D, Xu, J‑H, Yu T, Li J‑Y, Zhao L‑N, Ouyang H, Luo S, Lu X‑J, Huang C‑Z, Lan Q‑S et al: Knockdown of linc‑POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer. Oncotarget 7: 961‑975, 2016]. Finally, an independent investigation of these data in the Editorial Office revealed that, in addition to the data shared between Figs. 2 and 5, there were overlapping data panels both within Fig. 5C and within the wound healing assay data shown in Fig. 3B. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, and given the number of cases of overlapping data panels both within and between figures in the artce itself, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they did not agree with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 44: 1194‑1295, 2020; DOI: 10.3892/or.2020.7670]
- 20 March 2023
- Published by Spandidos Publications in Oncology Reports
- Vol. 49 (5) , 1
RetractionOpen Access[Retracted] Long noncoding RNA UCID sponges miR‑152‑3p to promote colorectal cancer cell migration and invasion via the Wnt/β‑catenin signaling pathway
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that there appeared to be matching data panels comparing between the Transwell invasion and migration assays shown in Figs. 2C and 5C; moreover, one of the data panels shown in Fig. 2D had previously appeared in a paper written largely by different authors (the author ‘T‑D Shan’ was held in common) at different research institutes in the journal Oncotarget in 2016 [Shan T‑D, Xu, J‑H, Yu T, Li J‑Y, Zhao L‑N, Ouyang H, Luo S, Lu X‑J, Huang C‑Z, Lan Q‑S et al: Knockdown of linc‑POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer. Oncotarget 7: 961‑975, 2016]. Finally, an independent investigation of these data in the Editorial Office revealed that, in addition to the data shared between Figs. 2 and 5, there were overlapping data panels both within Fig. 5C and within the wound healing assay data shown in Fig. 3B. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, and given the number of cases of overlapping data panels both within and between figures in the artce itself, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they did not agree with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 44: 1194‑1295, 2020; DOI: 10.3892/or.2020.7670]
- Open Access
- 13 March 2023
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 25 (4) , 1-4
A solitary rectal juvenile polyp with chicken skin‑like changes in the surrounding mucosa in an adult: A case report
The majority of colorectal polyps in adults are adenomatous polyps, while hamartoma polyps are rare. Juvenile polyps are the most common type of polyp in children; however, they are rare in adults. Fecal calprotectin (FCP) is commonly elevated in inflammatory bowel disease and is rarely studied in juvenile rectal polyps. Reports of elevated FCP in solitary juvenile rectal polyps of adults are rare. A 57‑year‑old female was admitted to The Affiliated Hospital of Qingdao University (Qingdao, China) for treatment due to intermittent stool with mucus and blood. Colonoscopy revealed a solitary polyp in the rectum with a diameter of ~2.0 cm, a short and wide subpedicle, with congested and swollen mucosa on the surface and chicken skin‑like changes in the surrounding mucosa. The patient had no family history of colorectal polyps or cancer. Endoscopic submucosal dissection was used to remove the polyp. Histopathological examination indicated that the polyp was a juvenile polyp and no signs of malignancy were found. The present case report describes details on this case of an adult patient with a solitary juvenile rectal polyp with chicken skin‑like changes in the surrounding mucosa and high FCP.
- 13 March 2023
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 25 (4) , 1-4
Open AccessA solitary rectal juvenile polyp with chicken skin‑like changes in the surrounding mucosa in an adult: A case report
The majority of colorectal polyps in adults are adenomatous polyps, while hamartoma polyps are rare. Juvenile polyps are the most common type of polyp in children; however, they are rare in adults. Fecal calprotectin (FCP) is commonly elevated in inflammatory bowel disease and is rarely studied in juvenile rectal polyps. Reports of elevated FCP in solitary juvenile rectal polyps of adults are rare. A 57‑year‑old female was admitted to The Affiliated Hospital of Qingdao University (Qingdao, China) for treatment due to intermittent stool with mucus and blood. Colonoscopy revealed a solitary polyp in the rectum with a diameter of ~2.0 cm, a short and wide subpedicle, with congested and swollen mucosa on the surface and chicken skin‑like changes in the surrounding mucosa. The patient had no family history of colorectal polyps or cancer. Endoscopic submucosal dissection was used to remove the polyp. Histopathological examination indicated that the polyp was a juvenile polyp and no signs of malignancy were found. The present case report describes details on this case of an adult patient with a solitary juvenile rectal polyp with chicken skin‑like changes in the surrounding mucosa and high FCP.
- Open Access
- 20 July 2021
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1
Correction to: Silencing long non-coding RNA CASC9 inhibits colorectal cancer cell proliferation by acting as a competing endogenous RNA of miR-576-5p to regulate AKT3
- 20 July 2021
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1
Open AccessCorrection to: Silencing long non-coding RNA CASC9 inhibits colorectal cancer cell proliferation by acting as a competing endogenous RNA of miR-576-5p to regulate AKT3